UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.314

Sortiert nach

Dietary poorly absorbed, short‐chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon

Alimentary pharmacology & therapeutics, 2010-04, Vol.31 (8), p.874-882

2010

Link zum Volltext

Verfügbarkeit prüfen

Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome

Journal of human nutrition and dietetics, 2011-10, Vol.24 (5), p.487-495

2011

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders

Alimentary pharmacology & therapeutics, 2009-07, Vol.30 (2), p.165-174

2009

Link zum Volltext

Verfügbarkeit prüfen

Clinical effectiveness and economic costs of group versus one‐to‐one education for short‐chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome

Journal of human nutrition and dietetics, 2015-12, Vol.28 (6), p.687-696

2015

Link zum Volltext

Verfügbarkeit prüfen

Factors associated with thiopurine non‐adherence in patients with inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2013-11, Vol.38 (9), p.1097-1108

2013

Link zum Volltext

Verfügbarkeit prüfen

Review article: appropriate use of corticosteroids in Crohn’s disease

Alimentary pharmacology & therapeutics, 2007-08, Vol.26 (3), p.313-329

2007

Link zum Volltext

Verfügbarkeit prüfen

Review article: malignancy on thiopurine treatment with special reference to inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2010-07, Vol.32 (2), p.119-130

2010

Link zum Volltext

Verfügbarkeit prüfen

Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients

Alimentary pharmacology & therapeutics, 2014-12, Vol.40 (11-12), p.1313-1323

2014

Link zum Volltext

Verfügbarkeit prüfen

Long‐term impact of the low‐FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability, and healthcare utilization in irritable bowel syndrome

Neurogastroenterology and motility, 2018-01, Vol.30 (1), p.n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Infliximab and adalimumab drug levels in Crohn's disease: contrasting associations with disease activity and influencing factors

Alimentary pharmacology & therapeutics, 2017-07, Vol.46 (2), p.150-161

2017

Link zum Volltext

Verfügbarkeit prüfen

Factors Associated With Nonadherence to Thiopurines in Adolescent and Adult Patients With Inflammatory Bowel Disease

Journal of pediatric gastroenterology and nutrition, 2012-05, Vol.54 (5), p.685-689

2012

Link zum Volltext

Verfügbarkeit prüfen

Mechanism of allopurinol induced TPMT inhibition

Biochemical pharmacology, 2013-08, Vol.86 (4), p.539-547

2013

Link zum Volltext

Verfügbarkeit prüfen

Editorial: different tests for different drugs in Crohn’s disease, or different tests for different people? Authors’ reply

Alimentary pharmacology & therapeutics, 2017-08, Vol.46 (4), p.465-465

2017

Link zum Volltext

Verfügbarkeit prüfen

Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers

Pharmaceutical research, 1994-12, Vol.11 (12), p.1800-1808

1994

Link zum Volltext

Verfügbarkeit prüfen

Prebiotic β-galacto-oligosaccharide impact on clinical, inflammatory and microbiota outcomes in active ulcerative colitis: an open-label study

Proceedings of the Nutrition Society, 2020, Vol.79 (OCE1), Article E10

2020

Link zum Volltext

Verfügbarkeit prüfen

Poster presentations at medical conferences: an effective way of disseminating research?

Clinical medicine (London, England), 2011-04, Vol.11 (2), p.138-141

2011

Link zum Volltext

Verfügbarkeit prüfen

Gastrointestinal: Rapunzel syndrome

Journal of gastroenterology and hepatology, 2007-12, Vol.22 (12), p.2361-2361

2007

Link zum Volltext

Verfügbarkeit prüfen

OP02 Ustekinumab versus adalimumab for induction and maintenance therapy in Moderate-to-Severe Crohn’s Disease: The SEAVUE study

Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S001-S002

2021

Link zum Volltext

Verfügbarkeit prüfen

Leucocytapheresis for ulcerative colitis

Digestive and liver disease, 2004-12, Vol.36 (12), p.799-802

2004

Link zum Volltext

Verfügbarkeit prüfen

Setting priorities for comparative effectiveness research in inflammatory bowel disease: Results of an international provider survey, expert rand panel, and patient focus groups

Inflammatory bowel diseases, 2012-12, Vol.18 (12), p.2294-2300

2012

Link zum Volltext

Verfügbarkeit prüfen

Prebiotic intake in habitual diet is not associated with luminal bifidobacteria concentration in irritable bowel syndrome

Proceedings of the Nutrition Society, 2014, Vol.73 (OCE1), Article E20

2014

Link zum Volltext

Verfügbarkeit prüfen

Cost analysis of screening according to ECCO guidelines for prevention of opportunistic infections in infliximab-treated ibd patients

Gut, 2011-04, Vol.60 (Suppl 1), p.A142-A142

2011

Link zum Volltext

Verfügbarkeit prüfen

Utilisation of anti-TNF levels in a UK tertiary IBD centre

Frontline gastroenterology, 2017-07, Vol.8 (3), p.189-195

2017

Link zum Volltext

Verfügbarkeit prüfen

Anxiety and psychological stress in acute severe ulcerative colitis: prevalence and effect on outcome

Gut, 2011-04, Vol.60 (Suppl 1), p.A222-A222

2011

Link zum Volltext

Verfügbarkeit prüfen

Reassessment of Crohn's disease treated with at least 12 months of anti-TNF therapy: how likely is treatment withdrawal?

Frontline gastroenterology, 2014-07, Vol.5 (3), p.176-182

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.314

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.962)
Mit Volltextzugriff
(2.066)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.376)
Life Sciences & Biomedicine
(1.124)
Humans
(995)
Male
(576)
Female
(544)
Biological And Medical Sciences
(489)
Medical Sciences
(401)
Adult
(385)
Middle Aged
(343)
Animals
(336)
Aged
(267)
Adolescent
(169)
Physical Sciences
(140)
Surgery
(137)
Cardiovascular System & Cardiology
(124)
Fundamental And Applied Biological Sciences. Psychology
(121)
Patients
(111)
Treatment Outcome
(110)
Cardiac & Cardiovascular Systems
(109)
Technology
(106)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

Dietary poorly absorbed, short‐chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon

Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome

Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders

Clinical effectiveness and economic costs of group versus one‐to‐one education for short‐chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome

Factors associated with thiopurine non‐adherence in patients with inflammatory bowel disease

Review article: appropriate use of corticosteroids in Crohn’s disease

Review article: malignancy on thiopurine treatment with special reference to inflammatory bowel disease

Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients

Long‐term impact of the low‐FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability, and healthcare utilization in irritable bowel syndrome

Infliximab and adalimumab drug levels in Crohn's disease: contrasting associations with disease activity and influencing factors

Factors Associated With Nonadherence to Thiopurines in Adolescent and Adult Patients With Inflammatory Bowel Disease

Mechanism of allopurinol induced TPMT inhibition

Editorial: different tests for different drugs in Crohn’s disease, or different tests for different people? Authors’ reply

Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers

Prebiotic β-galacto-oligosaccharide impact on clinical, inflammatory and microbiota outcomes in active ulcerative colitis: an open-label study

Poster presentations at medical conferences: an effective way of disseminating research?

Gastrointestinal: Rapunzel syndrome

OP02 Ustekinumab versus adalimumab for induction and maintenance therapy in Moderate-to-Severe Crohn’s Disease: The SEAVUE study

Leucocytapheresis for ulcerative colitis

Setting priorities for comparative effectiveness research in inflammatory bowel disease: Results of an international provider survey, expert rand panel, and patient focus groups

Prebiotic intake in habitual diet is not associated with luminal bifidobacteria concentration in irritable bowel syndrome

Cost analysis of screening according to ECCO guidelines for prevention of opportunistic infections in infliximab-treated ibd patients

Utilisation of anti-TNF levels in a UK tertiary IBD centre

Anxiety and psychological stress in acute severe ulcerative colitis: prevalence and effect on outcome

Reassessment of Crohn's disease treated with at least 12 months of anti-TNF therapy: how likely is treatment withdrawal?

Suchergebnisse filtern